Johnson Fistel, PLLP is investigating claims on behalf of long-term shareholders of Treace Medical Concepts, Inc. for alleged breaches of fiduciary duty by certain officers and directors. The investigation follows allegations that Treace made false or misleading statements about its business, including the impact of competition on its main product and revenue decline. Shareholders who held shares since before May 8, 2023, may seek corporate governance reforms and potential recovery at no cost. This could lead to changes in company oversight and financial restitution if claims succeed.
Hovnanian Enterprises reported Q3 revenue of $705.75 million and an EPS of -$0.70, both below analyst expectations due to delivery delays and weak joint venture income. Despite the earnings miss, the company exceeded its adjusted gross margin guidanc...
Youdao reported strong Q2 2026 results, with earnings per share of $0.11 beating estimates of $0.02 and revenue rising 3.5% year-over-year to $216.20 million. The company achieved its eighth consecutive quarter of operating profitability, recording a...
ScanSource reported strong Q4 results with non-GAAP earnings of $1.46 per share, surpassing estimates by over 31%, and net sales rising 17.3% to $953.11 million driven by hardware demand and growth in North America. The company announced a $220.5 mil...
Scotiabank raised its price target for Simon Property Group to $222 from $220 while maintaining a neutral Sector Perform rating. The real estate trust reported a 19.5% revenue increase to $1.79 billion in Q2 2026, with stable 96% occupancy at its U.S...
UiPath CEO Daniel Dines has sold 1.4 million shares of the company, raising $22.5 million. This move may indicate a personal liquidity event or portfolio rebalancing by the CEO. Investors might watch for any impact on the stock price or future inside...
